Local Ablative Therapy for Treatment of Oligoprogressive, EGFR-Mutated, Non-Small Cell Lung Cancer After Treatment With Osimertinib
Clinical trial NCT02759835 · COMPLETED
Trial details
- NCT number
- NCT02759835
- Sponsor
- National Cancer Institute (NCI)
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-04-13
- Primary completion
- 2022-05-25
- Enrollment
- 37
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.